- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IND Swift Laboratories Ltd (ISLB)
IND Swift Laboratories Ltd stock price live, this page displays NSE ISLB stock exchange data. View the ISLB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IND Swift Laboratories Ltd real time stock price chart below.
What Is the IND Swift Laboratories Ltd Stock Price Today?
The IND Swift Laboratories Ltd stock price today is 361.05.
What Is the Stock Symbol for IND Swift Laboratories Ltd?
The stock symbol for IND Swift Laboratories Ltd is "ISLB."
What Stock Exchange Does IND Swift Laboratories Ltd Trade On?
IND Swift Laboratories Ltd is listed and trades on the NSE stock exchange.
Is IND Swift Laboratories Ltd a Good Stock to Buy?
Determining whether IND Swift Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ISLB quote. (ISIN: INE915B01019)
What Is the IND Swift Laboratories Ltd Stock Price Today?
The IND Swift Laboratories Ltd stock price today is 361.05.
What Is the Stock Symbol for IND Swift Laboratories Ltd?
The stock symbol for IND Swift Laboratories Ltd is "ISLB."
What Stock Exchange Does IND Swift Laboratories Ltd Trade On?
IND Swift Laboratories Ltd is listed and trades on the NSE stock exchange.
Is IND Swift Laboratories Ltd a Good Stock to Buy?
Determining whether IND Swift Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ISLB quote. (ISIN: INE915B01019)
361.05
+0.15(+0.04%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
355.00
373.20
52 wk Range
87.15
424.75
INDSWFTLAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
355.00373.20
52 wk Range
87.15424.75
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
INDSWFTLAB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 10, 2026
EPS / Forecast
2.84 / --
Revenue / Forecast
1.91B / --
Compare INDSWFTLAB to Peers and Sector
Metrics to compare | INDSWFTLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINDSWFTLABPeersSector | |
|---|---|---|---|---|
P/E Ratio | 54.8x | 30.9x | −0.3x | |
PEG Ratio | −0.70 | 0.28 | 0.00 | |
Price/Book | 2.3x | 4.1x | 2.6x | |
Price / LTM Sales | 4.7x | 3.7x | 3.0x | |
Upside (Analyst Target) | - | 10.1% | 59.8% | |
Fair Value Upside | Unlock | −0.1% | 7.1% | Unlock |
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson’s disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ind Swift Lab (INDSWFTLAB) Stock Price Today?
The Ind Swift Lab stock price today is 361.05 INR.
What Stock Exchange Does Ind Swift Lab Trade On?
Ind Swift Lab is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Ind Swift Lab?
The stock symbol for Ind Swift Lab is "INDSWFTLAB."
What Is the Ind Swift Lab Market Cap?
As of today, Ind Swift Lab market cap is 31.41B INR.
What Is Ind Swift Lab's Earnings Per Share (TTM)?
The Ind Swift Lab EPS (TTM) is 6.47.
From a Technical Analysis Perspective, Is INDSWFTLAB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Ind Swift Lab Stock Split?
Ind Swift Lab has split 0 times.
How Many Employees Does Ind Swift Lab Have?
Ind Swift Lab has 1388 employees.
What is the current trading status of Ind Swift Lab (INDSWFTLAB)?
As of Oct 12, 2026, Ind Swift Lab (INDSWFTLAB) is trading at a price of 361.05 INR, with a previous close of 361.05 INR. The stock has fluctuated within a day range of 355.00 INR to 373.20 INR, while its 52-week range spans from 87.15 INR to 424.75 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.